{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T06:00:57Z","timestamp":1788328857633,"version":"build-2803163510"},"reference-count":90,"publisher":"Informa UK Limited","issue":"5","funder":[{"name":"Deanship of Scientific Research at Imam Mohammad Ibn Saud Islamic University","award":["IMSIU-DDRSP2601"],"award-info":[{"award-number":["IMSIU-DDRSP2601"]}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Therapeutic Patents"],"published-print":{"date-parts":[[2026,5,4]]},"DOI":"10.1080\/13543776.2026.2660910","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T11:38:22Z","timestamp":1776253102000},"page":"435-458","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["A patent review of VEGFR-2 inhibitors: an update (2022 \u2013 present)"],"prefix":"10.1080","volume":"36","author":[{"given":"Thoraya A.","family":"Farghaly","sequence":"first","affiliation":[{"name":"Umm Al-Qura University","place":["Makkah Almukkarramah, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa F.","family":"Harras","sequence":"additional","affiliation":[{"name":"Al-Azhar University","place":["Cairo, Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amani M. R.","family":"Alsaedi","sequence":"additional","affiliation":[{"name":"Taif University","place":["Taif, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sami A.","family":"Al-Hussain","sequence":"additional","affiliation":[{"name":"Imam Mohammad Ibn Saud Islamic University (IMSIU)","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia T.","family":"Al-Qurashi","sequence":"additional","affiliation":[{"name":"Umm Al-Qura University","place":["Makkah Almukkarramah, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayed M.","family":"Riyadh","sequence":"additional","affiliation":[{"name":"University of Cairo","place":["Giza, Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdi E. A.","family":"Zaki","sequence":"additional","affiliation":[{"name":"Imam Mohammad Ibn Saud Islamic University (IMSIU)","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shadia M.","family":"Hussein","sequence":"additional","affiliation":[{"name":"Cairo University Hospital, Cairo University","place":["Giza, Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,4,26]]},"reference":[{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2025.109164"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2025.109106"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2025.109140"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2025.118679"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2016.194"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1159\/000088478"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2025.108702"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2025.110949"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10456-009-9160-6"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph17010081"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1039\/D4RA05244G"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2025.108920"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2025.118187"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12272-025-01545-1"},{"key":"e_1_3_5_17_1","unstructured":"Chuanlong G Mei Z Yian W et al. A VEGFR-2 inhibitor and its preparation and application. CN 115463119 A. 2022."},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107059"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1080\/13543776.2017.1344215"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.medidd.2019.100009"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2025.118304"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2025.130423"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmgh.2024.101454"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2020.104532"},{"key":"e_1_3_5_25_1","unstructured":"Kumar M. Compounds as anticancer agent and a process for preparation therefor. EP 4 286 382 A1. National Institute of Technology Karnataka (NITK); 2023."},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.3390\/cryst13111546"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27154898"},{"key":"e_1_3_5_28_1","unstructured":"Abilizi M Zheng Y Zhengye L et al. New nitrogen-containing heterocyclic chalcone derivative and its preparation method and application. CN 117603127 A. 2023."},{"key":"e_1_3_5_29_1","unstructured":"Pengcheng Z Danxia Y Guowu R et al. Biscarboxamido-tetrazine compounds as VEGFR-2 inhibitors and their preparation and use. CN 115322163 A. 2024."},{"key":"e_1_3_5_30_1","unstructured":"Pengcheng Z Shuang R Guowu R et al. Substituted phenyl dimethyl tetrazine carboxamide compounds and their preparation and application. CN 115260113 A. 2022."},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1039\/d1ra08055e"},{"key":"e_1_3_5_32_1","unstructured":"Qian WS Wang HS Tan LS et al. Salt from and crystal form of pyrazole substituted imidazo[1 2-a]quinoxaline derivative PCT\/CN2022\/071598. WO 2022\/166548 EP 4 286 386 A1. 2023."},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.2174\/0113852728274686231204053638"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.4c00239"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28020689"},{"key":"e_1_3_5_36_1","unstructured":"Patil AB Baheti KG. ETHYL 2-(((1 H-benzo[D]imidazol-2-yl)methyl)amino)thiazole-4-carboxylatederivatives as VEGFR-2 inhibitors. IN202321089289. 2024."},{"key":"e_1_3_5_37_1","unstructured":"Chen Z Dai M Zhang Y et al. Crystal from of methylpyrazole-substituted pyridoimidazole compound and preparation method therefor. EP 4 286 382 A1. 2022."},{"key":"e_1_3_5_38_1","unstructured":"Xu Y Wang H Mi C et al. 2 3-dimthoxy-5-methyl-l 4-benzoquinone alkyl alcohol derivative and use thereof. CA 3235127 A1. 2023."},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.2174\/1871520621666211118102139"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28073203"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2024.107644"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph17020216"},{"key":"e_1_3_5_43_1","unstructured":"Zhao L Deng J Zhang L et al. Oxindole derivative and pharmaceutical use thereof. WO 2022\/126441 Al. 2022."},{"key":"e_1_3_5_44_1","unstructured":"Yuhui Z. An indole derivative and its application. CN116120284A. 2023."},{"key":"e_1_3_5_45_1","unstructured":"Zhibing Z Pengyun L Song L et al. Quinoline compounds and their preparation methods pharmaceutical compositions and medical uses. CN116751161A. 2022."},{"key":"e_1_3_5_46_1","unstructured":"Zhibing Z Pengyun L Song L et al. Substituted naphthamide derivatives and their medical uses. CN 115417867 A. 2022."},{"key":"e_1_3_5_47_1","unstructured":"Junjie M Yali G Jieqing L et al. A quinazoline derivative containing a benzofuran Structure and its application. CN 117285518 A. 2023."},{"key":"e_1_3_5_48_1","unstructured":"Yang C Yang G Zhou H. Quinazoline derivative and preparation method therefor and use thereof. PCT\/CN2022\/131932 WO 2023\/226323 Al."},{"key":"e_1_3_5_49_1","unstructured":"Xiaoqing Z Kankan S Lingyu Z. An antitumor compound used as a VEGFR inhibitor and its use. CN 114957136 A. 2022."},{"key":"e_1_3_5_50_1","unstructured":"Niefang Y Jinfu D Wei X et al. A pyrimidine derivative and its preparation method and application. CN 115925684 A. 2023."},{"key":"e_1_3_5_51_1","unstructured":"Wei X Wei Y Jiang N. Use of pyrrolotriazine compound in preparation of anti-tumor drug PCT Int. Appl. WO 2024\/017229 Al. 2024."},{"key":"e_1_3_5_52_1","unstructured":"Shiwu C Xingrong W. A 1H-indazole VEGFR-2 kinase inhibitor and its preparation and application. CN 114276297 A. 2022."},{"key":"e_1_3_5_53_1","unstructured":"Khasimbi S Wakode S Manda K et al. Quinazoline-2-amine derivatives as anti-tumor agents. India IN202411035375 A. 2024."},{"key":"e_1_3_5_54_1","unstructured":"Zhai Y Yang D Wang G et al. Combination therapies for treating cancer. U.S. 2023\/0404998 Al. 2023."},{"key":"e_1_3_5_55_1","unstructured":"Antonius DMAP Christian BR Gerard SJ et al. MIL reversible macrocyclic kinase inhibitors. WO 2023\/110936 Al Netherlands. 2023."},{"key":"e_1_3_5_56_1","unstructured":"Niefang Y Jinfu D Wei X et al. A pyrazolo[1 5-a]pyridine derivative and its preparation method and application. CN 115772170 A. 2023."},{"key":"e_1_3_5_57_1","unstructured":"Bannen L Xu W Raub A et al. Pyridone compounds and methods of use. WO 2022\/178205 Al. 2022."},{"key":"e_1_3_5_58_1","unstructured":"De Falco S Ruvo M Giuliano F et al. Peptides for inhibiting angiogenesis. WO 2022\/162030 Al. 2022."},{"key":"e_1_3_5_59_1","unstructured":"Xu J Wang Z Wang D et al. Composition and use of slRnas against VEGFR2 and TGFpI in combination therapy for cancer. WO 2023\/288141. 2023."},{"key":"e_1_3_5_60_1","unstructured":"Chadjaa M Dennis P. Antitumor combinations containing anti-ceacam5 antibody-drug coniugates anti-VEGFR-2 antibodies and anti-PD1\/PD-Ll antibodies. WO 2024\/184349 Al. 2024."},{"key":"e_1_3_5_61_1","unstructured":"Voloshin-Sela T Klein-Goldberg A Avigdor L. Compositions systems and methods for treating cancer using tumor treating fields and anti-VEGFR-2 antibodies. WO 2024\/141995 Al. 2024."},{"key":"e_1_3_5_62_1","unstructured":"Plutzky J Tzani A. FAM222A as a therapeutic target. WO 2025\/097153 Al. 2025."},{"key":"e_1_3_5_63_1","unstructured":"Liu Y Hou Q Wang Y. Anti-VEGF and PD-1 bispecific antibodies and uses thereof. WO 2025\/193962 Al. 2025."},{"key":"e_1_3_5_64_1","unstructured":"Sun Z Wang X Qi H. Use of compound or pharmaceutically acceptable salt dimer or trimer thereof in preparation of drug for treating cancer. EP 3 964 217 A1. 2025."},{"key":"e_1_3_5_65_1","unstructured":"Francis B Hernandez G Jovylyn G et al. Methods of treating advanced solid tumors. US WO 2024\/137751 Al. 2024."},{"key":"e_1_3_5_66_1","unstructured":"Mingyuan C Rui Y. A drug for treating recurrent or metastatic nasopharyngeal carcinoma and a marker for evaluating its efficacy. CN 114788869 A. 2022."},{"key":"e_1_3_5_67_1","unstructured":"Evangelista M Merchant M Schutzman JL et al. Methods and compositions comprising a krasg12c inhibitor and a vegf inhibitor for treating solid tumors. WO 2022\/103905 Al. 2022."},{"key":"e_1_3_5_68_1","unstructured":"Maser P Lacher S Stebegg M et al. Combinations of halogenated heterocyclic kinase inhibitors and vegfr inhibitors. WO 2025\/157389 Al. 2025."},{"key":"e_1_3_5_69_1","unstructured":"Garcia Fortanet J Asmussen GT Goodwin JM et al. Hetero aryl modulators of apmap and uses thereof. WO 2025\/194014 Al. 2025."},{"key":"e_1_3_5_70_1","unstructured":"Loftsson T Stefans E On S. Preparation of solid cyclodextrin complexes for ophthalmic active pharmaceutical ingredient delivery. US 2023\/0263907 Al. 2023."},{"key":"e_1_3_5_71_1","unstructured":"Teh BLD Lin Q Tan SWQ et al. Polymer composition comprising a thermogelling polymer and a tyrosine kinase inhibitor and related methods thereof. WO 2025\/058571 Al. 2025."},{"key":"e_1_3_5_72_1","unstructured":"Rodgers JT Le DH Bhatnagar R et al. Use of VEGFR2 and FGFR1 inhibitors in therapy. PCT\/US2023\/068247 WO 2023\/240271 Al. 2023."},{"key":"e_1_3_5_73_1","unstructured":"Bhatnagar R Martinez FJ Pipathsouk AW et al. Methods & compositions for treating dermal atrophy. WO 2025\/193959 Al. 2025."},{"key":"e_1_3_5_74_1","unstructured":"Widder MW Carbaugh CM Schalie WHV et al. Novel rapid drugdiscovery for sepsis and agents for use as sepsistherapy. US 2025\/0085273 \u03911. 2025."},{"key":"e_1_3_5_75_1","doi-asserted-by":"publisher","DOI":"10.2174\/138920009788897975"},{"key":"e_1_3_5_76_1","doi-asserted-by":"publisher","DOI":"10.2174\/1389200218666170105165832"},{"key":"e_1_3_5_77_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2009-0317"},{"key":"e_1_3_5_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2005.01.005"},{"key":"e_1_3_5_79_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21082793"},{"key":"e_1_3_5_80_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19041232"},{"key":"e_1_3_5_81_1","doi-asserted-by":"publisher","DOI":"10.1159\/000488087"},{"key":"e_1_3_5_82_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.689132"},{"key":"e_1_3_5_83_1","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2018.8733"},{"key":"e_1_3_5_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2025.189323"},{"key":"e_1_3_5_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110785"},{"key":"e_1_3_5_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioactmat.2025.04.026"},{"key":"e_1_3_5_87_1","doi-asserted-by":"publisher","DOI":"10.1080\/13543776.2021.1935872"},{"key":"e_1_3_5_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2024.101149"},{"key":"e_1_3_5_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2023.115626"},{"key":"e_1_3_5_90_1","doi-asserted-by":"publisher","DOI":"10.1039\/d5ra05685c"},{"key":"e_1_3_5_91_1","doi-asserted-by":"publisher","DOI":"10.2174\/0118715206356712241202112641"},{"key":"e_1_3_5_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2025.118023"}],"container-title":["Expert Opinion on Therapeutic Patents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13543776.2026.2660910","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T13:48:14Z","timestamp":1777902494000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13543776.2026.2660910"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,26]]},"references-count":90,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5,4]]}},"alternative-id":["10.1080\/13543776.2026.2660910"],"URL":"https:\/\/doi.org\/10.1080\/13543776.2026.2660910","relation":{},"ISSN":["1354-3776","1744-7674"],"issn-type":[{"value":"1354-3776","type":"print"},{"value":"1744-7674","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,26]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ietp20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ietp20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-12-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}